Integrative translational discovery of vascular risk factors in aging and dementia
衰老和痴呆血管危险因素的综合转化发现
基本信息
- 批准号:9421402
- 负责人:
- 金额:$ 357.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeAgingAllelesAlzheimer&aposs DiseaseAlzheimer&aposs Disease PathwayAlzheimer&aposs disease riskAmyloid beta-ProteinApolipoprotein EAutopsyBiochemicalBiologicalBiological ModelsBlood VesselsBrainBrain DiseasesCellsChIP-seqChromatinClinicClinicalCognitiveComplexDataData SetDementiaDiseaseDrug TargetingElderlyEnvironmental Risk FactorEpigenetic ProcessEtiologyEventFundingGene ProteinsGenerationsGenesGeneticGenetic RiskGenetic TranscriptionGenotypeGoalsGonadal Steroid HormonesGrantHeterogeneityHumanInflammatoryKnowledgeLeadMeasurementMeasuresMedicineMeta-AnalysisMethylationModelingMolecularMusNerve DegenerationNeurofibrillary TanglesOutcomeParentsParticipantPathologicPathway AnalysisPathway interactionsPatientsPhenotypePlasmaProspective cohortProtein IsoformsRNA SequencesRiskRisk FactorsRoleSamplingScienceSenile PlaquesTestingTissue SampleTissuesUnited States National Institutes of Healthapolipoprotein E-3biomarker discoverycohortdata sharingdrug discoveryendophenotypefunctional genomicsfunctional outcomesgenome-widehuman datalipid metabolismmetabolomemetabolomicsmethylomemouse modelnetwork modelsneuroimagingneuropathologynew therapeutic targetnovelparent grantprogramsproteostasisresponsesextargeted biomarkertau Proteinstranscriptome
项目摘要
PROJECT SUMMARY/ABSTRACT
Alzheimer's disease (AD) is the most common cause of dementia characterized by brain accumulation of
senile plaques and neurofibrillary tangles. AD risk is likely influenced by a multitude of genetic and
environmental risk factors and their complex interplay, which subsequently lead to cascades of downstream
pathophysiologic events that include but are not limited to aberrant proteostasis and lipid metabolism, as well
as inflammatory, vascular, and oxidative mechanisms. The array of risk factors that lead to AD and their
downstream influences are likely to be heterogeneous amongst AD patients, which complicates the search for
drug targets, biomarkers and their potential downstream beneficial use in any given AD patient. For this
reason, drug target and biomarker discovery efforts in AD have to focus on identification of both molecular
mechanisms that are commonly perturbed in AD patients, as well as those mechanisms that may underlie
heterogeneity in AD. To overcome this massive challenge, team-science efforts, including the NIH initiatives,
Accelerating Medicines Partnership-AD (AMP-AD) and Molecular Mechanisms of the Vascular Etiology of AD
(M2OVE-AD) Consortia, have launched large-scale generation and analyses of multi-omics data from well-
phenotyped human cohorts and model systems. These consortia aim to integrate multi-omics and clinical
endophenotype data to build a model(s) of AD that captures these common and heterogeneous
pathomechanisms. Our teams are leading participants of both AMP-AD and M2OVE-AD. The initial findings
from these consortia reveal concerted changes in networks of expressed genes and proteins in AD subjects
and model systems, with biological significance. Despite this progress and wide and immediate sharing of the
data generated by these programs, significant gaps remain in the available –omics data, and the ability to
integrate, harmonize and annotate these datasets. Our proposal is in response to the RFA-AG-17-054, which
aims to close these gaps. In this proposal, we maintain the overall objective of our parent funded M2OVE-AD
project (RF1 AG51504), which is to determine APOE- and sex-dependent effects, and uncover novel genes
and pathways that influence vascular risk in aging, AD and other dementias. Our specific aims are: 1.
Integrative functional genomic analysis of human brains to discover novel pathways in AD. 2. Integrative
functional genomic analysis in a prospective cohort to validate and discover AD pathways. 3. Investigate the
impact of APOE genotype and sex on transcriptional networks and the metabolome in model systems. 4.
Perform single-cell profiling to annotate the transcriptome data from AMP-AD and M2OVE-AD. These studies
will add key epigenetic data (H3K9Ac and RRBS methylome) to the human and transcriptome and
metabolomics data to the mouse cohorts, generate human and mouse single cell transcriptome data, and
perform integrative network analyses. We expect this proposal to fill key gaps in knowledge and further
enhance the AMP-AD and M2OVE-AD initiatives in their drug and biomarker discovery goals.
项目总结/摘要
阿尔茨海默氏病(AD)是痴呆的最常见原因,其特征在于脑内积聚的
老年斑和神经纤维缠结。AD风险可能受到多种遗传因素的影响,
环境风险因素及其复杂的相互作用,随后导致下游的级联
病理生理事件,包括但不限于异常蛋白质稳态和脂质代谢,以及
炎症、血管和氧化机制。导致AD的一系列风险因素及其
下游影响在AD患者中可能是异质性的,这使得寻找
药物靶标、生物标志物及其在任何给定AD患者中的潜在下游有益用途。为此
因此,AD中的药物靶点和生物标志物发现工作必须集中在识别两种分子
这些机制通常在AD患者中受到干扰,以及那些可能导致
AD的异质性。为了克服这个巨大的挑战,团队科学的努力,包括国家卫生研究院的倡议,
加速药物伙伴关系-AD(AMP-AD)及其血管病因的分子机制
(M2 OVE-AD)联盟,已经启动了大规模的多组学数据的生成和分析,
表型确定的人类群组和模型系统。这些联盟旨在整合多组学和临床
内表型数据来构建AD模型,该模型捕获这些常见和异质的
病理机制我们的团队是AMP-AD和M2 OVE-AD的主要参与者。初步结果
揭示了AD患者表达基因和蛋白质网络的协同变化
和模型系统,具有生物学意义。尽管取得了这一进展,并广泛和立即分享了
尽管这些计划产生的数据,但可用的组学数据仍存在重大差距,
整合、协调和注释这些数据集。我们的提案是对RFA-AG-17-054的回应,
旨在缩小这些差距。在本提案中,我们保持了母公司资助的M2 OVE-AD的总体目标
项目(RF 1 AG 51504),该项目旨在确定APOE和性别依赖性效应,并发现新基因
以及影响衰老、AD和其他痴呆症血管风险的途径。我们的具体目标是:1.
人类大脑的综合功能基因组分析,以发现AD的新途径。2.综合
在前瞻性队列中进行功能基因组分析,以验证和发现AD途径。3.探讨
APOE基因型和性别对模型系统中转录网络和代谢组的影响。4.
进行单细胞分析以注释来自AMP-AD和M2 OVE-AD的转录组数据。这些研究
将为人类和转录组添加关键的表观遗传数据(H3 K9 Ac和RRBS甲基化组),
将代谢组学数据提供给小鼠群组,生成人和小鼠单细胞转录组数据,以及
进行综合网络分析。我们希望这一提议能够填补知识方面的关键空白,并进一步
加强AMP-AD和M2 OVE-AD在其药物和生物标志物发现目标方面的举措。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GUOJUN BU其他文献
GUOJUN BU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GUOJUN BU', 18)}}的其他基金
TREM2-mediated microglial dynamic function in Alzheimer disease
TREM2 介导的阿尔茨海默病小胶质细胞动态功能
- 批准号:
9914464 - 财政年份:2020
- 资助金额:
$ 357.77万 - 项目类别:
TREM2-mediated microglial dynamic function in Alzheimer disease
TREM2 介导的阿尔茨海默病小胶质细胞动态功能
- 批准号:
10088365 - 财政年份:2020
- 资助金额:
$ 357.77万 - 项目类别:
Integrative translational discovery of vascular risk factors in aging and dementia
衰老和痴呆血管危险因素的综合转化发现
- 批准号:
9001610 - 财政年份:2015
- 资助金额:
$ 357.77万 - 项目类别:
ApoE isoform-specific therapy for Alzheimer disease
ApoE 异构体特异性治疗阿尔茨海默病
- 批准号:
8744260 - 财政年份:2013
- 资助金额:
$ 357.77万 - 项目类别:
ApoE isoform-specific therapy for Alzheimer disease
ApoE 异构体特异性治疗阿尔茨海默病
- 批准号:
9104070 - 财政年份:2013
- 资助金额:
$ 357.77万 - 项目类别:
ApoE isoform-specific therapy for Alzheimer disease
ApoE 异构体特异性治疗阿尔茨海默病
- 批准号:
9291405 - 财政年份:2013
- 资助金额:
$ 357.77万 - 项目类别:
ApoE isoform-specific therapy for Alzheimer disease
ApoE 异构体特异性治疗阿尔茨海默病
- 批准号:
8894356 - 财政年份:2013
- 资助金额:
$ 357.77万 - 项目类别:
ApoE isoform-specific therapy for Alzheimer disease
ApoE 异构体特异性治疗阿尔茨海默病
- 批准号:
8608893 - 财政年份:2013
- 资助金额:
$ 357.77万 - 项目类别:
BRAIN LIPID METABOLISM, DENDRITES AND SYNAPSES IN AGING AND ALZHEIMER'S DISEASE
衰老和阿尔茨海默病中的脑脂质代谢、树突和突触
- 批准号:
8183828 - 财政年份:2010
- 资助金额:
$ 357.77万 - 项目类别:
BRAIN LIPID METABOLISM, DENDRITES AND SYNAPSES IN AGING AND ALZHEIMER'S DISEASE
衰老和阿尔茨海默病中的脑脂质代谢、树突和突触
- 批准号:
8721290 - 财政年份:2010
- 资助金额:
$ 357.77万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 357.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 357.77万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 357.77万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 357.77万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 357.77万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 357.77万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 357.77万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 357.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 357.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 357.77万 - 项目类别:
Operating Grants